<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Data of the two assays were analyzed by a non-linear curve fit model using GraphPad Prism 5.04 software (GraphPad, La Jolla, CA, USA) and the Kd value was calculated. General screening was performed using the optimal concentration of membrane with a radioligand concentration less than or equals to the Kd. Each compound was tested at 10 μM in triplicates. The assays were performed as stated above. Non-specific binding was subtracted from total binding to find specific binding. Percent binding was determined using the following equation: 
 <disp-formula id="FD1-molecules-22-01384" class="disp-formula">
  <math id="mm1" class="math">
   <mrow class="mrow">
    <mrow class="mrow">
     <mo class="mo">%</mo>
     <mtext class="mtext"> </mtext>
     <mi class="mi">binding</mi>
     <mo class="mo">=</mo>
     <mn class="mn">100</mn>
     <mo class="mo">−</mo>
     <mrow class="mrow">
      <mo class="mo">(</mo>
      <mrow class="mrow">
       <mfrac class="mfrac">
        <mrow class="mrow">
         <mi class="mi">Compound</mi>
         <mtext class="mtext"> </mtext>
         <mi class="mi">CPM</mi>
         <mo class="mo">−</mo>
         <mi class="mi">nonspecific</mi>
         <mtext class="mtext"> </mtext>
         <mi class="mi">CPM</mi>
        </mrow>
        <mrow class="mrow">
         <mi class="mi">specific</mi>
         <mtext class="mtext"> </mtext>
         <mi class="mi">CPM</mi>
        </mrow>
       </mfrac>
      </mrow>
      <mo class="mo">)</mo>
     </mrow>
     <mo class="mo">×</mo>
     <mn class="mn">100</mn>
    </mrow>
   </mrow>
  </math>
 </disp-formula>
</p>
